<DOC>
	<DOCNO>NCT00904982</DOCNO>
	<brief_summary>The purpose research study see lottery provide opportunity win money , reminder system use `` Med-eMonitor '' , combination might useful help patient achieve good control anticoagulation therapy . Selection arm study randomize study computer . Some participate daily lottery , reminder system , reminder system daily lottery , neither lottery reminder system .</brief_summary>
	<brief_title>Randomized Trial Interventions Improve Warfarin Adherence</brief_title>
	<detailed_description>Eligible subject enrol one 4 arm RCT follow 6 month , primary outcome out-of-range INRs . Subjects give Med-eMonitor connect home phone line . For subject , use measure daily adherence . Subjects incentive group eligible daily lottery prize , prior lottery resolve , adherence device register adherence prescribe warfarin regimen . Subjects MM group reminder/feedback feature Med-eMonitor turn provide reminder take warfarin prescribe standardized message use provide feedback response adherence . Subjects combine group expose lottery activate Med-eMonitor . This trial randomize control trial . Both men woman least 18 year age prescribe anticoagulation medication eligible participate .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Key Inclusion Criteria The study population include patient study site : 1. maintenance phase warfarin treatment ( define use standard method period time follow 2 consecutive visit , least 7 day apart , stable target INR initiation drug ) 2. whose provider indicate expect stay treatment least 6 month 3. target INR 2 3.5 4. least one INR participant 's target range within 90 day prior enrollment ( exclude baseline visit ) and/or INR baseline visit participant 's target range 5. work analog telephone line . Of note , patient within target INR range enroll ; specifically want include target range time study entry may patient likely nonadherent . Key Exclusion Criteria Patients exclude meet inclusion criterion , 1. INR screen target range 2. less 18 year age give consent 3. read 6th grade read level 4. enrol clinical trial warfarin therapy 5. unable adequately follow study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>warfarin</keyword>
	<keyword>coumadin</keyword>
	<keyword>adherence</keyword>
	<keyword>mechanical heart valve</keyword>
</DOC>